The Search for an AIDS Vaccine: Ethical Issues in the Development and Testing of a Preventive HIV Vaccine (Medical Ethics)
Health and Life (Free subscription) | yesterday
From a small clustering of men with Karposi’s sarcoma and Pneumocystis pneumonia in the early 1980s, HIV/AIDS has quickly become a pandemic that has killed more than 25 million people to date. Despite relatively inefficient mode of transmission, HIV continues to spread throughout the world, and is projected to infect at least another 50 million [...]
Tuscaloosanews.com (Free subscription) | 11/26/2009
The Associated Press WASHINGTON | The failure of an experimental AIDS vaccine trial two years ago may have been caused by the common cold virus. The vaccine was intended to block the spread of HIV, which causes AIDS. But the test was canceled after volunteers who got the shots were more likely to become infected than those who got a dummy shot.
Market Wire (Free subscription) | 11/25/2009
WASHINGTON, DC (MARKET WIRE) In honor of World AIDS Day, The AIDS Institute (TAI), one of the nation's leading advocacy organizations for support of people with HIV/AIDS and their providers, joined Nobel Laureate Dr. Francoise Barre-Sinoussi, in calling for government leaders, patient advocates and the research community to expand therapeutic HIV vaccine research.
Physorg (Free subscription) | 11/25/2009
An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. Sékaly from the Université de Montréal. "This...
HIV This Week (Free subscription) | 11/25/2009
Welcome to the 74th issue of HIV This Week ! In this issue we cover biomedical interventions: vaccines (a proof-of-concept breakthrough in Thailand invigorates HIV vaccine scientists and activists around the world; why investing in vaccine research holds promise in the United States), paediatric HIV testing (Kwazulu Natal points the ...
Newswise (Free subscription) | 11/25/2009
In honor of World AIDS Day, The AIDS Institute (TAI), one of the nation's leading advocacy organizations for support of people with HIV/AIDS and their providers, joined Nobel Laureate Dr. Francoise Barre-Sinoussi, in calling for government leaders, patient advocates and the research community to expand therapeutic HIV vaccine research.
Joe. My. God. (Free subscription) | 11/24/2009
The Pharmaceutical Research and Manufacturers Association writes us today in advance of World AIDS Day (December 1st) to let us know about the 97 HIV/AIDS medications currently in the research pipeline. Conservatively, an effective HIV vaccine could prevent almost 30 million of the 150 million new infections projected in the coming decades. A highly effective vaccine could even prevent more than 70...
Proceedings of the National Academy (Free subscription) | 11/24/2009
In the recently halted HIV type 1 (HIV-1) vaccine STEP trial, individuals that were seropositive for adenovirus serotype 5 (Ad5)...
Medical News Today (Free subscription) | 11/24/2009
The Associated Press/News-Observer examines revitalized vaccine research, including for such conditions as malaria, TB and HIV. "Vaccines are no longer a sleepy, low-profit niche in a booming drug industry. Today, they're starting to give ailing pharmaceutical makers a shot in the arm," according to the article.
Fight HIV in DC (Free subscription) | 11/23/2009
The next CAVE meeting will take place December 9th at 7:00 PM at the DC Center, 1111 14th Street NW Suite 350. Our meetings normally take place the second Wednesday of each month. The meeting will include a mini-presentation and discussion on The HIV Vaccine Trials Network Group Meeting recently held in Seattle. Please join us! CAVE ( www.aidsvaccine.org ) is the community advisory board for the Vaccine...
Science Daily (Free subscription) | 11/23/2009
An HIV virus modified to infect monkeys could be a big step forward for HIV research
Physorg (Free subscription) | 11/19/2009
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Science Mag (Free subscription) | 11/19/2009
Despite significant efforts, an effective vaccine against the HIV-1 virus remains elusive. A site on the HIV-1 gp120 envelope glycoprotein that binds to the CD4 receptor on host cells is … [Read more]
Science Daily (Free subscription) | 11/19/2009
The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus 'shell' used to transmit the therapy around the body, according to new research. The researchers behind the study say their findings mean scientists may have to rethink other vaccines they are developing for diseases like HIV, tuberculosis and malaria, which are delivered in the same way, using the same...
Pro-Life News (Free subscription) | 11/19/2009
The Associated Press Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it. Many could be on the market in...
Videos